ConductScience.org, home

Paper9836772

Diffusion-weighted magnetic resonance imaging confirms marked neuroprotective efficacy of albumin therapy in focal cerebral ischemia.

Belayev L and 7 others. Stroke, 1998. Cited by 136 papers, by iCite.

Cite this record

ConductScience Library. Diffusion-weighted magnetic resonance imaging confirms marked neuroprotective efficacy of albumin therapy in focal cerebral ischemia. Papers, record 9836772. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9836772

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Diffusion-weighted magnetic resonance imaging confirms marked neuroprotective efficacy of albumin therapy in focal cerebral ischemia.
PubMed
Journal
Stroke
PubMed
Year
1998
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
136
iCite
Relative citation ratio, by iCite
3.86
iCite
Revised in PubMed
2019-07-27
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Belayev LL
2Zhao WW
3Pattany PMP M
4Weaver RGR G
5Huh PWP W
6Lin BB
7Busto RR
8Ginsberg MDM D

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Brain IschemiaMajor topic
Magnetic Resonance ImagingMajor topic
Neuroprotective AgentsMajor topic
Serum AlbuminMajor topic
Animals
Brain
Brain Edema
Diffusion
Endothelium, Vascular
Humans
Male
Microglia
Rats
Rats, Sprague-Dawley

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
NS05820NINDS NIH HHSUnited StatesP01NS005820PubMed and NIHNIH RePORTER
P50NS005820NIHNIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in12511738Beneficial effect of albumin therapy attributable to alpha1-acid glycoprotein?https://conductscience.org/library/papers/12511738

Source PubMed

Download CSV of comments and corrections

Cited by49

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 136 citations.

PMIDTitleJournalYearIn PapersSource
42156639Intra-Arterial Selective Hypothermic Human Serum Albumin Perfusion Attenuates Cerebral Ischemia-Reperfusion Injury.Transl Stroke Res2026https://conductscience.org/library/papers/42156639PubMed
42010254Efficacy and safety of albumin combined with endovascular therapy in the treatment of patients with acute ischemic stroke: a randomized clinical trial.Nat Commun2026https://conductscience.org/library/papers/42010254PubMed
41468394Early combination of albumin with crystalloids administration might not be beneficial for the survival of ischemic stroke patients with sepsis: A retrospective analysis from MIMIC‑IV database.PLoS One2025https://conductscience.org/library/papers/41468394PubMed
41003011Essential Amino Acid Supplementation May Attenuate Systemic Inflammation and Improve Hypoalbuminemia in Subacute Hemiplegic Stroke Patients.Metabolites2025https://conductscience.org/library/papers/41003011PubMed
40944047A Comprehensive Review of Fluid Resuscitation Strategies in Traumatic Brain Injury.J Clin Med2025https://conductscience.org/library/papers/40944047PubMed
40757028Albumin for patients with acute large-vessel occlusive stroke undergoing endovascular therapy (ARISE): the protocol of a randomized double-blind trial.Front Neurol2025https://conductscience.org/library/papers/40757028PubMed
39403266Albumin adjuvant therapy for acute ischemic stroke with large vessel occlusion (AMASS-LVO): rationale, design, and protocol for a phase 1, open-label, clinical trial.Front Neurol2024https://conductscience.org/library/papers/39403266PubMed
38192834Acute albumin administration as therapy for intracerebral hemorrhage: A literature review.Heliyon2024https://conductscience.org/library/papers/38192834PubMed
36969491Correlation Analysis of Neutrophil/Albumin Ratio and Leukocyte Count/Albumin Ratio with Ischemic Stroke Severity.Cardiol Cardiovasc Med2023https://conductscience.org/library/papers/36969491PubMed
35544482Optimizing acute stroke outcome prediction models: Comparison of generalized regression neural networks and logistic regressions.PLoS One2022https://conductscience.org/library/papers/35544482PubMed
33959442Frequency of Hypoalbuminemia and In-Hospital Mortality in Acute Ischemic Stroke Patients Presenting at a Tertiary Care Hospital, Hyderabad.Cureus2021https://conductscience.org/library/papers/33959442PubMed
33945037Albumin therapy for acute ischemic stroke: a meta-analysis.Neurol Sci2021https://conductscience.org/library/papers/33945037PubMed
33599834Investigation of brain damage mechanism in middle cerebral artery occlusion/reperfusion rats based on i-TRAQ quantitative proteomics.Exp Brain Res2021https://conductscience.org/library/papers/33599834PubMed
31565439Prognostic Value of Serum Albumin at Admission for Neurologic Outcome with Targeted Temperature Management after Cardiac Arrest.Emerg Med Int2019https://conductscience.org/library/papers/31565439PubMed
31412042The relationship between plasma amino acids and circulating albumin and haemoglobin in postabsorptive stroke patients.PLoS One2019https://conductscience.org/library/papers/31412042PubMed
30746015Serum Albumin as a Predictor of Functional Outcomes Following Acute Ischemic Stroke.J Vasc Interv Neurol2018https://conductscience.org/library/papers/30746015PubMed
28794441TGFβ signaling is associated with changes in inflammatory gene expression and perineuronal net degradation around inhibitory neurons following various neurological insults.Sci Rep2017https://conductscience.org/library/papers/28794441PubMed
28680300Repeated Oral Administration of Human Serum Albumin Protects from the Cerebral Ischemia in Rat Brain Following MCAO.Exp Neurobiol2017https://conductscience.org/library/papers/28680300PubMed
28598225A novel voxel-wise lesion segmentation technique on 3.0-T diffusion MRI of hyperacute focal cerebral ischemia at 1 h after permanent MCAO in rats.J Cereb Blood Flow Metab2018https://conductscience.org/library/papers/28598225PubMed
28586018Transient cerebral ischemia induces albumin expression in microglia only in the CA1 region of the gerbil hippocampus.Mol Med Rep2017https://conductscience.org/library/papers/28586018PubMed

See all 49 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9836772

GET https://conductscience.org/api/papers/v1/9836772/cited_by?page=2